Begin typing your search above and press return to search.
proflie-avatar
Login
exit_to_app
DEEP READ
Munambam Waqf issue decoded
access_time 16 Nov 2024 10:48 PM IST
Ukraine
access_time 16 Aug 2023 11:16 AM IST
Putin
access_time 2 Jan 2025 1:36 PM IST
What is Christmas?
access_time 26 Dec 2024 11:19 AM IST
exit_to_app
Homechevron_rightSciencechevron_rightLink between...

Link between inflammation and depression explored by researchers

text_fields
bookmark_border
Link between inflammation and depression explored by researchers
cancel

New Delhi: Researchers have revealed profound insights into the link between inflammation and depression, a discovery that could radically alter our knowledge of depression's biological underpinnings. Neuroscientist Raz Yirmiya's research at the Hebrew University of Jerusalem goes well beyond the lab.

His discoveries about the role of microglia cells and interleukin-1 in stress-induced depression raise intriguing questions about therapeutic interventions: How might understanding inflammatory processes lead to more targeted treatments? What role do different types of immune responses play in various forms of depression?

"Most depressed patients do not have any overt inflammatory disease. However, we and others found that exposure to stress, which is the most significant trigger of depression in humans and animals, also activates inflammatory processes, particularly in the brain," Yirmiya explained in a comprehensive Genomic Press Interview published in the journal Brain Medicine, IANS reported.

Through innovative approaches combining molecular techniques with behavioural studies, Yirmiya's team identified several promising therapeutic targets.

Their work on microglial checkpoint mechanisms and stress resilience opens new avenues for understanding how the immune system influences mental health. These findings suggest the potential for developing personalised treatments based on individual inflammatory profiles.

"My overarching aim is to harness the extensive knowledge from my research and others to accelerate the development of novel antidepressant therapeutics targeting inflammatory processes," said Yirmiya.

His work suggests that both activation and suppression of the immune system can trigger depressive symptoms, highlighting the need for personalised treatment approaches.

Yirmiya’s Genomic Press interview is part of a larger series that highlights the people behind today’s most influential scientific ideas.

Each interview in the series offers a blend of cutting-edge research and personal reflections, providing readers with a comprehensive view of the scientists shaping the future, said authors.

Show Full Article
TAGS:depressionresearchersinflammation
Next Story